SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ZILA--test for oral cancer?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: j.d.robbins who wrote (49)7/12/1996 9:10:00 PM
From: Julio P. Antelo   of 61
 
FDA approval: who knows?

J.D. FDA approval (by the way, some people call this the Food and Drug Administration, I prefer 'foot dragging androids') is a process that is totally unpredictable. It could come next week, or next October or who knows when. ZILA's management is busy working to satisfy all requirements but only time will tell. In an article in the Arizona Republic last month Joe Hines (ZILA's pres) hinted that they expect approval in the fall.

As far as the price of the stock, ZILA's performance has been, in my estimation, impressive in view of the selloff we've seen in the NASDAQ in the last couple of weeks. ZILA continues to trade in a tight range between $7-$8. I will not add to my position in the $8 range as I feel that is a little too steep a price. But if it happens to fall to say $5-$6, you bet I'll be buying more. Good luck. Julio
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext